Larina V N, Raspopova T N
Pirogov Russian National Research Medical University,Moscow, Russia.
Diagnostic Clinical Center 1, Moscow, Russia.
Kardiologiia. 2016 Jul;56(7):39-46. doi: 10.18565/cardio.2016.7.39-46.
to assess the state of bone metabolism and mineral density in outpatients with chronic heart failure (CHF).
We examined 70 outpatients (30 men, 40 women, aged 56-88 years) with CHF and 40 outpatients without CHF (10 men, 30 women, aged 57-88 years). Examination included laboratory assessment, echocardiography, study of bone mineral density (BMD) in the lumbar spine and femoral neck using dual-energy X-ray absorptiometry.
Osteoporosis was recorded in 61.4 and 32.4%, osteopenia - in 20 and 42.5%, normal BMD - in 18.6 and 25% of patients with and without CHF, respectively. A total of 24.3 and 7.5% of patients with and without CHF, respectively, experienced various bone fractures during mean follow up of 26.5 months. Significant correlation was established between osteoporosis and patient's age (r=0.36; p=0.002), CHF duration (r=0.26; p=0.039), falls (r=0.29; p=0.015), fractures (r=0.42; <0.001), chronic kidney disease - CKD (r=0.24; =0.048), N-proBNP (r=0.52; =0.007), GFR (r=-0.37; =0.010). In unifactorial analysis osteoporosis was associated with CKD (odds ratio [R] 3.1, 95% confidence interval [CI] 1.1-8.8, p=0.032 , N-proBNP (R 9.8, 95% CI 1.1-8.9, =0.043) and frequent alls (R 4.0, 95% CI 1.3-12.7; =0.019).
Association of high N-proBNP level and abnormal renal function with lowered BMD allows to suggest that low BMD is an independent marker of CHF severity, and patients with CHF are at high risk of osteoporosis and related fractures.
评估慢性心力衰竭(CHF)门诊患者的骨代谢状态和骨密度。
我们检查了70例CHF门诊患者(30名男性,40名女性,年龄56 - 88岁)和40例非CHF门诊患者(10名男性,30名女性,年龄57 - 88岁)。检查包括实验室评估、超声心动图,使用双能X线吸收法测量腰椎和股骨颈的骨密度。
CHF患者和非CHF患者中,骨质疏松的发生率分别为61.4%和32.4%,骨量减少的发生率分别为20%和42.5%,骨密度正常者分别为18.6%和25%。在平均26.5个月的随访期间,CHF患者和非CHF患者发生各种骨折的比例分别为24.3%和7.5%。骨质疏松与患者年龄(r = 0.36;p = 0.002)、CHF病程(r = 0.26;p = 0.039)、跌倒(r = 0.29;p = 0.015)、骨折(r = 0.42;<0.001)、慢性肾脏病 - CKD(r = 0.24;=0.048)、N - proBNP(r = 0.52;=0.007)、肾小球滤过率(GFR)(r = -0.37;=0.010)之间存在显著相关性。单因素分析显示,骨质疏松与CKD(比值比[R] 3.1,95%置信区间[CI] 1.1 - 8.8,p = 0.032)、N - proBNP(R 9.8,95% CI 1.1 - 8.9,=0.043)和频繁跌倒(R 4.0,95% CI 1.3 - 12.7;=0.019)有关。
高N - proBNP水平和肾功能异常与骨密度降低相关,这表明低骨密度是CHF严重程度的独立标志物,CHF患者发生骨质疏松和相关骨折的风险较高。